Hepatic Hilar Lymph Node Resection in Cytoreductive Surgery for Advanced Ovarian Cancer: A Necessity or Not?
Huang H, Wei R, Long Y, Mo Y, Xie Y, Yao D.
Cancer Manag Res. 2021 Oct 20;13:7981-7988. doi: 10.2147/CMAR.S334658. eCollection 2021.
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
Altorki N, Wang X, Kozono D, Watt C, Landrenau R, Wigle D, Port J, Jones DR, Conti M, Ashrafi AS, Liberman M, Yasufuku K, Yang S, Mitchell JD, Pass H, Keenan R, Bauer T, Miller D, Kohman LJ, Stinchcombe TE, Vokes E.
N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083.
[Membrane anatomy-based splenic hilar lymph node dissection for gastric cancer].
Shen J, Zhang B, Wei W, Zhang JP.
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Jul 25;26(7):633-638. doi: 10.3760/cma.j.cn441530-20230407-00106.
Vascular invasion and lymph node metastasis mediate the effect of CA242 on prognosis in hilar cholangiocarcinoma patients after radical resection.
Heng G, Huang B, Shen Y, Wang D, Lan Z, Yao Y, Zhang J, Jia J, Zhang C.
Front Oncol. 2022 Dec 12;12:1071439. doi: 10.3389/fonc.2022.1071439. eCollection 2022.
Provider and procedural factors associated with guideline-concordant lymph node sampling in lung cancer resection.
Williams JE, Jacobs RC, Savitch SL, Hollenbeck ME, Pratt J, Bylsma R, Mollberg N, Reddy RM, Lagisetty KH, Odell DD.
J Thorac Cardiovasc Surg. 2025 Sep;170(3):864-875.e2. doi: 10.1016/j.jtcvs.2025.04.015. Epub 2025 May 4.
[Current status of intraoperative lymph node dissection for hilar cholangiocarcinoma].
Guan JF, Wang K.
Zhonghua Wai Ke Za Zhi. 2020 Jan 1;58(1):48-51. doi: 10.3760/cma.j.issn.0529-5815.2020.01.011.
Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma.
Liu ZP, Zhang QY, Chen WY, Huang YY, Zhang YQ, Gong Y, Jiang Y, Bai J, Chen ZY, Dai HS.
J Gastrointest Surg. 2022 May;26(5):1030-1040. doi: 10.1007/s11605-021-05211-x. Epub 2022 Jan 1.
The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: Results from Cancer and Leukemia Group B 140503 (Alliance).
Altorki N, Damman B, Wang X, Liberman M, Wigle D, Ashrafi A, Conti M, Yasufuku K, Schuchert MJ, Stinchcombe TE.
J Thorac Cardiovasc Surg. 2025 Oct;170(4):933-942.e2. doi: 10.1016/j.jtcvs.2025.06.007. Epub 2025 Jun 16.
Comparison between lymph and non-lymph node resection in patients with stage IA non-small-cell lung cancer: A retrospective study.
Lei B, Zhang Z, Li C, Yang J, Peng J, Zhao Y, Liu G, Liang H, Feng J, Xiang X.
J Cancer Res Ther. 2024 Dec 1;20(7):2094-2102. doi: 10.4103/jcrt.jcrt_131_24. Epub 2025 Jan 10.
Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection.
Resio BJ, Tan KS, Skovgard M, Dycoco J, Adusumilli PS, Bains MS, Bott MJ, Downey RJ, Gray KD, Huang J, Molena D, Park BJ, Rusch VW, Sihag S, Rocco G, Jones DR, Isbell JM.
Ann Thorac Surg. 2025 Feb;119(2):308-315. doi: 10.1016/j.athoracsur.2024.09.009. Epub 2024 Sep 19.
